EIR Targanta Therapeutics, Aug 2008

Kimberly Martin FDA$595.00 - Available Now

FDA investigators audited the Targanta Therapeutics, - Indianapolis, IN, United States facility and issued inspectional observation (via FDA 483) on 29 Aug 2008.

Product details

  • Category:
  • Inspection end: 29 Aug 2008
  • Location: Indianapolis, United States
  • FEI: 3006849644
Add To Cart